The activation of α7nAChR inhibits Th1 and Th17 differentiation while promoting Treg differentiation, thereby reducing the severity of inflammation in experimental autoimmune encephalomyelitis and VMC (52, 53). Here, CHRNA7 is linked to experimental autoimmune encephalomyelitis.